The effects of letrozole and clomiphene citrate on ligands expression of Wnt3, Wnt7a, and Wnt8b in proliferative endometrium of women with Polycystic ovarian syndrome

Reproductive Health

Gonadotrophins or clomiphene citrate in women with normogonadotropic anovulation and CC failure: does the endometrium matter?

Hum Reprod.

Bordewijk EM, Weiss NS, Nahuis MJ, Kwee J, Lambeek AF, van Unnik GA, Vrouenraets FPJ, Cohlen BJ, van de Laar-van Asseldonk TAM, Lambalk CB, Goddijn M, Hompes PG, van der Veen F, Mol BWJ, van Wely M, M-ovin study group.

doi: 10.1093/humrep/deaa052.

Pregnancy and ChildbirthReproductive Health

First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis

Hum Reprod Update.

Wang R, Li W, Bordewijk EM, Legro RS, Zhang H, Wu X, Gao J, Morin-Papunen L, Homburg R, König TE, Moll E, Kar S, Huang W, Johnson NP, Amer SA, Vegetti W, Palomba S, Falbo A, Özmen Ü, Nazik H, Williams CD, Federica G, Lord J, Sahin Y, Bhattacharya S, Norman RJ, van Wely M, Mol BW, Reproductive Medicine Network+., International Ovulation Induction IPDMA Collaboration.

doi: 10.1093/humupd/dmz029.

HPV and Gynecologic Cancer

Long-term outcome of postmenopausal women with proliferative endometrium on endometrial sampling

Am J Obstet Gynecol.

Rotenberg O, Doulaveris G, Fridman D, Renz M, Kaplan J, Xie X, Goldberg GL, Dar P

doi: 10.1016/j.ajog.2020.06.045.

Further Publications Gynecology

Randomised controlled trial on the effect of clomiphene citrate and gonadotropin dose on ovarian response markers and IVF outcomes in poor responders

Hum Reprod

Moffat R, Hansali C, Schoetzau A, Ahler A, Gobrecht U, Beutler S, Raggi A, Sartorius G, De Geyter C

doi: 10.1093/humrep/deaa336

Further Publications UrologyFurther Publications Gynecology

Impact of a diagnosis of polycystic ovary syndrome on diet, physical activity and contraceptive use in young women: findings from the Australian Longitudinal Study of Women's Health

Hum Reprod.

Copp T, Cvejic E, McCaffery K, Hersch J, Doust J, Mol BW, Dokras A, Mishra G, Jansen J

doi: 10.1093/humrep/dez274.

Reproductive Health

The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome

Hum Reprod.

Dilaver N, Pellatt L, Jameson E, Ogunjimi M, Bano G, Homburg R, D Mason H, Rice S

doi: 10.1093/humrep/dez214.

Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype

Am J Obstet Gynecol.

Engmann L, Jin S, Sun F, Legro RS, Polotsky AJ, Hansen KR, Coutifaris C, Diamond MP, Eisenberg E, Zhang H, Santoro N; Reproductive Medicine Network

doi: 10.1016/j.ajog.2017.01.003.

Reproductive Health

Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation

Hum Reprod.

Mostinckx L, Segers I, Belva F, Buyl R, Santos-Ribeiro S, Blockeel C, Smitz J, Anckaert E, Tournaye H, De Vos M

doi: 10.1093/humrep/dez086.

Reproductive Health

Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome

Hum Reprod.

Henríquez S, Kohen P, Xu X, Villarroel C, Muñoz A, Godoy A, Strauss JF, Devoto L

doi: 10.1093/humrep/deaa098.

Related content

Gonadotrophins or clomiphene citrate in women with normogonadotropic anovulation and CC failure: does the endometrium matter?

First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis

Long-term outcome of postmenopausal women with proliferative endometrium on endometrial sampling

Randomised controlled trial on the effect of clomiphene citrate and gonadotropin dose on ovarian response markers and IVF outcomes in poor responders

Impact of a diagnosis of polycystic ovary syndrome on diet, physical activity and contraceptive use in young women: findings from the Australian Longitudinal Study of Women's Health

The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome

Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype

Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation

Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome